# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-22-099136
Filing Date
2022-09-12
Accepted
2022-09-12 09:16:24
Documents
14
Period of Report
2022-09-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2225624d1_8k.htm iXBRL | 8-K | 29468
2 | EXHIBIT 99.1 | tm2225624d1_ex99-1.htm | EX-99.1 | 12334
6 | GRAPHIC | tm2225624d1_ex99-1img001.jpg | GRAPHIC | 517722
| Complete submission text file | 0001104659-22-099136.txt |  | 935659

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | syn-20220912.xsd | EX-101.SCH | 3060
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | syn-20220912_lab.xml | EX-101.LAB | 34476
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | syn-20220912_pre.xml | EX-101.PRE | 22614
8 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2225624d1_8k_htm.xml | XML | 3615

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 221237729
SIC: 2834 Pharmaceutical Preparations